Skip to content

Drug interactions

Fingolimod + Lapatinib

Severity: Major

Fingolimod and Lapatinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lapatinib can prolong the QT interval, and fingolimod causes bradycardia and may add QT effects. The combination increases the risk of torsades de pointes, especially with electrolyte abnormalities.

What this interaction means in plain words

Fingolimod and Lapatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Fingolimod belongs to Central Nervous System; Lapatinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive QT prolongation with fingolimod-related bradycardia.

What to do

Obtain baseline ECG and electrolytes, correct hypokalemia and hypomagnesemia, and monitor ECG; consider alternatives in patients with other QT risk factors.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fingolimod and Lapatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fingolimod with Lapatinib?

MediHelp rates the interaction as major. Fingolimod and Lapatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lapatinib can prolong the QT interval, and fingolimod causes bradycardia and may add QT effects. The combination increases the risk of torsades de pointes, especially with electrolyte abnormalities.

How serious is the interaction between Fingolimod and Lapatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain baseline ECG and electrolytes, correct hypokalemia and hypomagnesemia, and monitor ECG; consider alternatives in patients with other QT risk factors.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in